742 related articles for article (PubMed ID: 34757513)
1. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
Hasan D; Shono A; van Kalken CK; van der Spek PJ; Krenning EP; Kotani T
Purinergic Signal; 2022 Mar; 18(1):13-59. PubMed ID: 34757513
[TBL] [Abstract][Full Text] [Related]
2. Purinergic receptors: new targets for the treatment of gout and fibrosis.
Gicquel T; Le Daré B; Boichot E; Lagente V
Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
[TBL] [Abstract][Full Text] [Related]
3. Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue.
Leão Batista Simões J; Fornari Basso H; Cristine Kosvoski G; Gavioli J; Marafon F; Elias Assmann C; Barbosa Carvalho F; Dulce Bagatini M
Int Immunopharmacol; 2021 Nov; 100():108150. PubMed ID: 34537482
[TBL] [Abstract][Full Text] [Related]
4. Nebulized Lidocaine in COVID-19, An Hypothesis.
Ali ZA; El-Mallakh RS
Med Hypotheses; 2020 Nov; 144():109947. PubMed ID: 32505070
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
[TBL] [Abstract][Full Text] [Related]
6. Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19.
Zarei M; Sahebi Vaighan N; Ziai SA
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):633-643. PubMed ID: 34647511
[TBL] [Abstract][Full Text] [Related]
7. Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus.
Kimura H; Yamazaki T; Mihara T; Kaji N; Kishi K; Hori M
J Vet Med Sci; 2022 Apr; 84(4):610-617. PubMed ID: 35249909
[TBL] [Abstract][Full Text] [Related]
8. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
9. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
[TBL] [Abstract][Full Text] [Related]
10. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
Root-Bernstein R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
[TBL] [Abstract][Full Text] [Related]
11. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
12. P2X7 purinergic receptor: A potential target in heart diseases (Review).
Bin Dayel AF; Alonazi AS; Alshammari TK; Alrasheed NM
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799169
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.
Barberà-Cremades M; Baroja-Mazo A; Gomez AI; Machado F; Di Virgilio F; Pelegrín P
FASEB J; 2012 Jul; 26(7):2951-62. PubMed ID: 22490780
[TBL] [Abstract][Full Text] [Related]
14. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
15. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.
Hernandez-Cedeño M; Venegas-Rodriguez R; Peña-Ruiz R; Bequet-Romero M; Santana-Sanchez R; Penton-Arias E; Martinez-Donato G; Guillén-Nieto G; Dominguez-Horta MDC
Cell Stress Chaperones; 2021 May; 26(3):515-525. PubMed ID: 33629254
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
Pelegrin P
Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm.
Batista Simões JL; Sobierai LD; Pereira SM; Rodrigues Dos Santos MV; Bagatini MD
Curr Pharm Des; 2022; 28(22):1798-1814. PubMed ID: 35838210
[TBL] [Abstract][Full Text] [Related]
18. The role and pharmacological properties of the P2X7 receptor in neuropathic pain.
Zhang WJ; Zhu ZM; Liu ZX
Brain Res Bull; 2020 Feb; 155():19-28. PubMed ID: 31778766
[TBL] [Abstract][Full Text] [Related]
19. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
20. Purinergic modulation of frog electroretinographic responses: The role of the ionotropic receptor P2X7.
Kupenova P; Popova E; Vitanova L
Vis Neurosci; 2017 Jan; 34():E015. PubMed ID: 28965497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
